It’s hard to believe, but later this week surgical sealant film manufacturer Tissuemed celebrates a decade of growing success. It’s ten years since the launch of TissuePatch during EACTS (European Association of Cardiothoracic Surgeons), in Geneva.
TissuePatch (or TissuePatch3 as it was then) was launched (see image) following 5 years of R&D, culminating in CE marking of the product as an aid to air leak prevention in thoracic surgery.
David Mandley, Tissuemed’s CEO recalls, “the Alps formed a spectacular backdrop to EACTS in 2007, so much so that they became an integral piece of our marketing literature when we launched TissuePatch.”
“The last 10 years have seen various product and process improvements all designed to support customer needs and distributor partners’ expectations. From modest origins the manufacturing scale of the TissuePatch product family has increased dramatically. Our sales capability has also evolved and grown during this period: Current investment means that Tissuemed’s domestic sales team boasts 5 dedicated colleagues who are meeting customers in hospital operating theatres every week.
“Tissuemed’s strongest pillar has to be the outstanding science and innovation that lies behind TissuePatch. The fact that today’s product is fundamentally similar to the original, suggests that the concept of a self-adhesive surgical sealant film was a good one. One could say we got it right first time, although that would be to underestimate the huge challenges we’ve faced as a team.”